Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirapazamine in advanced head and neck cancer
NCT00174837Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 17
01
Overview
Phase 3, randomised trial of tirapazamine in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Sanofi. Primary endpoint: Overall survival. Started Apr 2005; status: completed.
02
Drugs
tirapazamine
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00174837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174837.